Correlation between VEGF Expression and Angiogenesis in Breast Carcinoma

Analytical and Quantitative Cytology and Histology

Volumn 26, Issue 2, 2004, Pages 105-108

  Rajesh, Logasundaram ^a   Joshi, Kusum ^a   Veena, Bhalla ^a   Dey, Pranab ^a   Radotra, Bishan Das ^a   Nijhawan, Raje ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Angiogenesis, pathologic; Breast cancer; CD31 antigens; Endothelial growth factors; VEGF

Indexed keywords

CD31 ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DENSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TISSUE SECTION;

ANTIGENS, CD31; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1942503181     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Fox BS, Gatter KC, Harris AL: Tumor angiogenesis. J Pathol 1996;179:232-237
2. Harris AL, Zhang H, Moghaddaam A, Fox S, Scott P, Pattison A, Gatter K, Stratford I, Bicknell R: Breast cancer angiogenesis: New approaches to therapy via antiangiogenesis, hypoxic activated drugs and vascular targeting. Br Cancer Res Treat 1996;36:97-108
3. Hanahan D, Folkman J: Patterns and emerging mechanism of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364
4. Amoroso A, Del Porto F, Di Monaco C, Manfredini P, Afeltra A: Vascular endothelial growth factor: A key mediator of neoangiogenesis. Eur Rev Med Pharmacol Sci 1997;1:17-25
5. Horak ER, Lee KR, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewská K, Harris AL: Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies asindicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-1124
6. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: The value of histological grades in breast cancer: Experience from a large study with long term follow up. Histopathology 1991;19:403-410
7. Friersa HF Jr, Wolber RA, Berean KW, Framquemont DW, Gaffery MJ, Boyd JC, Wilbur DC: Interobserver reproducibility of Nottingham modification of the Bloom and Richardson histological grading scheme for infiltrating duct Carcinoma. Am J Clin Pathol 1995;103:195-198
8. Linderholm, B, Tavelin B, Grankvist K, Henriksson R: Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 1998;16: 2131-3128
9. Li HJ, Jing J, Zhao YB, Zhu JQ, Zhang SY, Shi ZD: Tumor angiogenesis in node-negative breast carcinoma. Ai Zheng 2002;21:75-78
10. Callagy G, Dimitriadis E, Harmey J, Bouchier-Hayes D, Leader M, Kay E: Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer: A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor. Appl Immunohistochem Mol Morphol 2000;8:104-109
11. Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB: VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. J Pathol 2001;193:325-332
12. Tokes AM, Hortovanyl E, Kulka J, Jackel M, Kerenyl T, Kadar A: Tenascin expression and angiogenesis in breast cancers. Pathol Res Pract 1999;195:821-828
13. Shimo T, Nakanishi T, Nishida T, Asano M, Sasaki A, Kanyama M, Kuboki T, Matsumura T, Takigawa M: Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 2001;61:315-322
14. Arora R, Joshi K, Nijhawan R, Radotra BD, Sharma SC: Angiogenesis as an independent prognostic indicator in node-negative breast cancer. Analyt Quant Cytol Histol 2002;24: 228-233
15. Miao RQ, Agata J, Chao L, Chao J: Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 2002;100: 3245-3252
16. Hasan J, Jayson GC: VEGF antagonists. Expert Opin Biol Ther 2001;1:703-718